Life-Saving Marathon Partners

SGLT2 Inhibitor Empagliflozin Treatment Stabilizes Kidney Function in Patients Who Have Had a Heart Attack

Mount Sinai Surgeons Perform First Heart-Liver-Kidney Transplants in New York State

A Novel Mechanism Links Lipoprotein(a) to Blood Clotting in the Arteries and Increased Risk of Heart Attack

Long COVID May Cause Long-Term Changes in the Heart and Lungs and May Lead to Cardiac and Pulmonary Diseases

AI Algorithm Can Help Identify High-Risk Heart Patients to Quickly Diagnose, Expedite, and Improve Care

Mount Sinai Fuster Heart Hospital Recognized by Press Ganey for Patient Experience Excellence

Monoclonal Antibody Can Reverse Effects of Bleeding and Complications Linked to Common Medication for Heart Attacks

Intravascular Imaging Can Improve Outcomes for Complex Stenting Procedures in Patients with High-Risk Calcified Coronary Artery Disease

A Patient’s Ability to Perform a Cardiac Stress Test Offers a Critical Window on Their Mortality Risk

A Diabetes, Heart Failure, and Kidney Disease Medication is the First of Its Kind to Significantly Reduce Both Heart Attacks and Strokes

An RNA Inhibitor Effectively Reduces a High-Risk Type of Cholesterol in Patients With Cardiovascular Disease